Towa Pharmaceutical Co's total assets for Q2 2026 were ¥480.53B, an increase of 1.12% from the previous quarter. JP:4553 total liabilities were ¥300.67B for the fiscal quarter, a -0.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.